Brief: Talaris Therapeutics Announces Pricing Of Initial Public Offering
07/05/2021 02:55
May 6 (Reuters) - Talaris Therapeutics Inc TALS.O :
* TALARIS THERAPEUTICS ANNOUNCES PRICING OF INITIAL PUBLIC
OFFERING
* SAYS INITIAL PUBLIC OFFERING OF 8.83 MILLION COMMON SHARES
PRICED AT $17.00PER SHARE
Source text for Eikon: ID:nGNX52RsJt
Further company coverage: TALS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tourmaline Bio
See all newsBrief: Novartis Completes Acquisition Of Tourmaline Bio
Brief: Novartis Announces Expiration Of Tourmaline Bio Tender Offer
Novartis nears deal to acquire Avidity Biosciences for over $70 per share, Bloomberg News reports (updated)
Brief: Novartis Announces Commencement Of Tender Offer To Acquire Tourmaline Bio
U.S. STOCKS ON THE MOVE-Potbelly, Joby, Talen Energy